நீல் பந்தர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நீல் பந்தர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நீல் பந்தர் Today - Breaking & Trending Today

Convergent Therapeutics and Point Biopharma Announce a Collaboration to Evaluate CONV 01-α (Rosopatamab-225Ac) in combination with PNT2002 for Progressive Metastatic Castration-Resistant Prostate Cancer

Convergent Therapeutics and Point Biopharma Announce a Collaboration to Evaluate CONV 01-α (Rosopatamab-225Ac) in combination with PNT2002 for Progressive Metastatic Castration-Resistant Prostate Cancer
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Paula Schwartz , Bernard Josephine Chaus , Joe Mccann , Alex Lobo , Scottt Tagawa , Philip Kantoff , Rx Communications Group , Cornell University , Biopharma Global Inc , Convergent Therapeutics Inc , Global Inc , Weill Cornell Medicine , Neil Bander , Josephine Chaus Professor , Urologic Oncology , Convergent Therapeutics , Chief Executive Officer , North America , Communications Group , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , பால ஸ்க்வார்ட்ஸ் , பெர்னார்ட் ஜோசபின் சாஸ் , ஓஹோ ம்க்க்யாந் ,

Convergent Therapeutics and Point Biopharma Announce a Collaboration to Evaluate CONV 01-α (Rosopatamab-225Ac) in combination with PNT2002 for Progressive Metastatic Castration-Resistant Prostate Cancer | Antibodies

Convergent Therapeutics and Point Biopharma Announce a Collaboration to Evaluate CONV 01-α (Rosopatamab-225Ac) in combination with PNT2002 for Progressive Metastatic Castration-Resistant Prostate Cancer | Antibodies
pipelinereview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pipelinereview.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Bernard Josephine Chaus , Joe Mccann , Scottt Tagawa , Philip Kantoff , I Convergent Therapeutics Inc , Cornell University , Biopharma Global Inc , Convergent Therapeutics Inc , Convergent Therapeutics , Point Biopharma Announce , Initiated Trial , Weill Cornell Medicine , Principal Investigator , United Statesi September , Global Inc , Neil Bander , Josephine Chaus Professor , Urologic Oncology , Chief Executive Officer , North America , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , பெர்னார்ட் ஜோசபின் சாஸ் , ஓஹோ ம்க்க்யாந் ,

Convergent Therapeutics and Point Biopharma Announce a Collaboration to Evaluate CONV 01-α (Rosopatamab-225Ac) in combination with PNT2002 for Progressive Metastatic Castration-Resistant Prostate Cancer

Convergent Therapeutics and Point Biopharma Announce a Collaboration to Evaluate CONV 01-α (Rosopatamab-225Ac) in combination with PNT2002 for Progressive Metastatic Castration-Resistant Prostate Cancer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Paula Schwartz , Bernard Josephine Chaus , Joe Mccann , Alex Lobo , Scottt Tagawa , Philip Kantoff , Rx Communications Group , Cornell University , Biopharma Global Inc , Convergent Therapeutics Inc , Global Inc , Weill Cornell Medicine , Neil Bander , Josephine Chaus Professor , Urologic Oncology , Convergent Therapeutics , Chief Executive Officer , North America , Communications Group , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , பால ஸ்க்வார்ட்ஸ் , பெர்னார்ட் ஜோசபின் சாஸ் , ஓஹோ ம்க்க்யாந் ,

Convergent Therapeutics Appoints Philip Kantoff, M.D. as Chief Executive Officer

Convergent Therapeutics Appoints Philip Kantoff, M.D. as Chief Executive Officer
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Paula Schwartz , Bernard Josephine Chaus , Philip Kantoff , Nancy Kohlberg , National Institutes Of Health , Drug Administration , Solid Tumor Oncology Division , Harvard Medical School , Harvard Medical School Kantoff , Rx Communications Group , Cornell University , Convergent Therapeutics Inc , Lank Center , Prostate Cancer Foundation Mentor Of Excellence Award , York University , Brown University , Dana Farber Cancer Institute , Department Of Medicine , Memorial Sloan Kettering Cancer Center , Chief Executive Officer , Josephine Chaus Professor , Urologic Oncology , Weill Cornell Medicine , Convergent Therapeutics , Nancy Kohlberg Chair ,

AIkido Pharma Provides Business Update

AIkido Pharma Provides Business Update
Drug Research and Development Progressing
Well-Capitalized to Further Efforts and Opportunistically Expand Portfolio
News provided by
Share this article
Share this article
NEW YORK, April 5, 2021 /PRNewswire/ AIkido Pharma Inc. (Nasdaq: AIKI) ( AIkido or the Company ) today provided a business update.
Anthony Hayes, CEO of AIkido Pharma, stated, AIkido s primary focus is the commercialization of improved treatments for multiple types of cancer and viral infections through innovative research and development that leverages the power of artificial intelligence and machine learning. Our research partners continue to make progress towards this focus with positive results in ongoing preclinical studies. In addition, through a series of financing transactions over the course of 2020, and the last several months, we are sufficiently capitalized to support our current efforts and to pursue additional emerging opport ....

United States , Scottt Tagawa , Anthony Hayes , Robert Dudley , Brett Maas , Paul Lemire , University Of Maryland At Baltimore , Aikido Pharma Inc , Source Aikido Pharma Inc , Silo Pharma Inc , Convergent Therapeutics Inc , Trademark Office , While The Company , University Of Texas At Austin , Drug Research , Mount Sinai Center , Trauma Research , Convergent Therapeutics , Neil Bander , Urologic Oncology , Weill Cornell , Silo Pharma , United States Patent , Scientific Advisory Board , Risk Factors , Pharma Inc ,